Ninlaro and Belching - a phase IV clinical study of FDA data

Summary:

Belching is reported as a side effect among people who take Ninlaro (ixazomib citrate), especially for people who are female, 60+ old, also take Pomalyst, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Belching when taking Ninlaro. It is created by eHealthMe based on reports of 19,558 people who have side effects when taking Ninlaro from the FDA, and is updated regularly.

What is Ninlaro?

Ninlaro has active ingredients of ixazomib citrate. eHealthMe is studying from 19,563 Ninlaro users. Check the latest studies of Ninlaro.

What is Belching?

Belching (release of gas from the digestive tract) is found to be associated with 940 drugs and 1,538 conditions by eHealthMe. Check the latest studies of Belching.

On Jul, 09, 2026

19,558 people reported to have side effects when taking Ninlaro.
Among them, 17 people (0.09%) have Belching.

Among these 17 people:

What is the gender of people who have Belching when taking Ninlaro? *

female: 70.59 %
male: 29.41 %

What is the age of people who have Belching when taking Ninlaro? *

What are other drugs people take besides Ninlaro? *

What are other side effects people have besides Belching? *

Diarrhea: 10 people, 58.82%
Flatulence (flatus expelled through the anus): 8 people, 47.06%
Indigestion: 6 people, 35.29%
Nausea And Vomiting: 5 people, 29.41%
Constipation: 5 people, 29.41%
Nausea (feeling of having an urge to vomit): 5 people, 29.41%
Abdominal Discomfort: 5 people, 29.41%
Dehydration (dryness resulting from the removal of water): 4 people, 23.53%
Dyspnea (difficult or laboured breathing): 4 people, 23.53%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 23.53%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 13 people, 76.47%
Stress And Anxiety: 3 people, 17.65%
Depression: 2 people, 11.76%
Pain: 1 person, 5.88%
Oedema (fluid collection in tissue): 1 person, 5.88%
Nausea (feeling of having an urge to vomit): 1 person, 5.88%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Ninlaro and have Belching?

- Check whether Belching is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ninlaro:

Ninlaro (19,563 reports)

Belching treatments and more:

Belching (19,372 reports)

Browse all side effects of Ninlaro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Belching:

Belching (940 drugs)

Browse all the conditions that are associated with Belching:

Belching (1,538 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ixazomib citrate (the active ingredients of Ninlaro) and Ninlaro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.